Stephanie Averette, NP
Nurse Practitioner · Columbia, SCNPI 1124113170
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,742 and has fallen 78.1% since, to $381 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $65.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Alkermes, Inc.$891
- Neurocrine Biosciences, Inc.$689
- AbbVie$414
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$310
- Gilead$251
- plus $2K from 13 others
What the payments were for
- Food & beverage$5,55199%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 43 | $1,130 |
| Alkermes, Inc. | 8 | $891 |
| Neurocrine Biosciences, Inc. | 6 | $689 |
| AbbVie | 4 | $414 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $310 |
| Gilead | 3 | $251 |
| Insmed, Inc. | 2 | $229 |
| Teva Pharmaceuticals USA, Inc. | 2 | $223 |
| Abbott | 2 | $218 |
| Vanda Pharmaceuticals Inc. | 2 | $208 |
| AstraZeneca | 2 | $207 |
| Argenx US, Inc. | 2 | $132 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| Sanofi | 1 | $125 |
| Mylan Specialty L.p. | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $117 |
| Cvrx, Inc. | 1 | $88 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| Genentech USA, Inc. | 1 | $62 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,767
- ARISTADA$1,460
- INGREZZA$467
- ARISTADA INITIO$365
- INVEGA SUSTENNA$238
- Epclusa$234
- VRAYLAR$227
- Fanapt$208
- CAPLYTA$127
- FREESTYLE LIBRE 3$125
- Arikayce$125
- QUVIVIQ$125
- DUPIXENT$125
- Yupelri$123
- VYVGART$122
- INVEGA TRINZA$117
- COBENFY$117
- AUSTEDO$101
How this compares
$5,626 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 71 | $31,524 |
| JanuviaSitagliptin Phosphate | 70 | $27,866 |
| EliquisApixaban | 19 | $7,839 |
| Lacosamide | 27 | $1,397 |
| Rivastigmine | 11 | $1,384 |
| Levothyroxine Sodium | 101 | $1,031 |
| Memantine Hcl | 40 | $873 |
| Amlodipine Besylate | 101 | $822 |
| Atorvastatin Calcium | 94 | $738 |
| Pantoprazole Sodium | 61 | $631 |
| Desmopressin Acetate | 19 | $572 |
| Metoprolol Succinate | 24 | $275 |
| Metformin Hcl | 66 | $198 |
| Atenolol | 12 | $128 |
| Hydrochlorothiazide | 17 | $77 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Columbia
- Melissa BramanteColumbia$19K
- Tonya MeltonColumbia$11K
- Andrea OatesColumbia$9K
- Meredith WatsonColumbia$9K
- Kimberly WillisColumbia$8K
- Leigh DavisColumbia$7K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.